[1]
2026. Engineering CRISPR-Cas13 Armed Bacteriophages to Combat Carbapenem Resistant Klebsiella pneumonia: A Targeted Antimicrobial Approach for Pakistan: https://doi.org/10.5281/zenodo.19941671. Pakistan Journal of Medical & Cardiological Review. 5, 2 (Apr. 2026), 979–995.